What are the Therapeutic Implications of miR-21 in Pediatrics?
Targeting miR-21 for therapeutic purposes is an area of active research. Antagomirs and other miRNA inhibitors are being developed to specifically inhibit miR-21 activity. These therapeutic agents could potentially be used to treat pediatric diseases where miR-21 is known to play a pathogenic role. However, more research is needed to ensure the safety and efficacy of these treatments in children.
